Concepedia

Publication | Open Access

Effectiveness of Monovalent and Pentavalent Rotavirus Vaccine

DOIFull Paper Access

119

Citations

30

References

2013

Year

Margaret M. Cortese, Lilly Cheng Immergluck, Melissa Held, Shabnam Jain, Trisha Chan, Alexandra P. Grizas, Saadia Khizer, Carol Barrett, Osbourne Quaye, Slavica Mijatovic-Rustempasic,
PEDIATRICS

Abstract

RV1 and RV5 were both highly effective against severe rotavirus disease. RV1 conferred sustained protection during the first 2 years of life and demonstrated high effectiveness against G2P[4] (heterotypic) disease.

References

YearCitations

Page 1